NK-lysin is an anti-microbial
peptide that plays a critical role in innate immunity against infectious pathogens through its selective membrane disruptive property. We previously expressed and purified a full-length chicken
NK-lysin (cNKL)
recombinant protein, and demonstrated its in vitro anti-parasitic activity against the apicomplexan protozoan, Eimeria, the etiologic agent of avian
coccidiosis. This study evaluated the in vitro and in vivo anti-parasitic properties of a synthetic
peptide (cNK-2) incorporating a predicted membrane-permeating, amphipathic α-helix of the full-length cNKL
protein. The cNK-2
peptide exhibited dose- and time-dependent in vitro cytotoxic activity against E. acervulina and E. tenella sporozoites. The cytotoxic activity of 1.5 μM of cNK-2
peptide against E. acervulina following 6h incubation was equal to that of 2.5 μM of
melittin, the principal active component of
apitoxin (
bee venom) that also exhibits anti-microbial activity. Even greater activity was detected against E. tenella, where 0.3 μM of cNK-2
peptide was equivalent to 2.5 μM of
melittin. Against Neospora caninum tacyzoites, however, the cytotoxic activity of cNK-2
peptide was inferior to that of
melittin. Transmission electron microscopy of
peptide-treated E. tenella sporozoites revealed disruption of the outer plasma membrane and loss of intracellular contents. In vivo administration of 1.5 μM of cNK-2
peptide increased protection against experimental E. acervulina
infection, as measured by greater
body weight gain and reduced fecal oocyst shedding, compared with saline controls. These results suggest that the cNK-2 synthetic
peptide is a novel anti-infective
peptide that can be used for protection against avian
coccidiosis during commercial poultry production.